ALG10

ALG10 alpha-1,2-glucosyltransferase, the group of Alpha-1,2-glucosyltransferases

Basic information

Region (hg38): 12:34022468-34029694

Links

ENSG00000139133 ∙ NCBI:84920 ∙ OMIM:618355 ∙ HGNC:23162 ∙ Uniprot:Q5BKT4 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ALG10 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALG10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous				2	2	4
missense			31	1	1	33
nonsense						0
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region						0
non coding						0
Total	0	0	31	3	3

Variants in ALG10

This is a list of pathogenic ClinVar variants found in the ALG10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
12-34022630-G-A		not specified	Uncertain significance (May 23, 2024)
12-34022631-C-A		not specified	Uncertain significance (May 23, 2024)
12-34022634-C-A		not specified	Uncertain significance (Feb 17, 2022)
12-34022650-T-G		not specified	Uncertain significance (May 16, 2022)
12-34022703-A-G		not specified	Uncertain significance (Jan 16, 2024)
12-34024007-A-G		not specified	Likely benign (May 26, 2022)
12-34024020-A-G		not specified	Uncertain significance (May 30, 2023)
12-34024041-G-C		not specified	Uncertain significance (Sep 16, 2021)
12-34024058-G-T		not specified	Uncertain significance (May 25, 2023)
12-34024062-G-A		not specified	Uncertain significance (May 24, 2023)
12-34024068-T-A		not specified	Uncertain significance (Dec 27, 2022)
12-34024080-G-A		not specified	Uncertain significance (Jul 14, 2021)
12-34024144-A-G		ALG10-related disorder	Likely benign (Nov 07, 2019)
12-34025866-G-A		not specified	Uncertain significance (Nov 04, 2022)
12-34025894-C-T		not specified	Uncertain significance (May 04, 2023)
12-34025895-A-C		ALG10-related disorder	Benign (Jul 03, 2018)
12-34025938-C-G		not specified	Uncertain significance (Mar 01, 2023)
12-34026036-T-G		not specified	Uncertain significance (Mar 01, 2023)
12-34026050-G-A		not specified	Uncertain significance (Dec 21, 2022)
12-34026073-G-C		not specified	Uncertain significance (Jan 19, 2024)
12-34026104-A-G		not specified	Uncertain significance (Jan 17, 2024)
12-34026110-C-T		not specified	Uncertain significance (Dec 15, 2022)
12-34026175-G-C		not specified	Uncertain significance (Mar 07, 2024)
12-34026222-C-T			Benign (Apr 05, 2018)
12-34026298-G-A			Benign (Dec 31, 2019)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
ALG10	protein_coding	protein_coding	ENST00000266483	3	7414

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
0.00000132	0.618	125695	0	53	125748	0.000211

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	-0.0283	234	233	1.01	0.0000112	3103
Missense in Polyphen		69	77.977	0.88488		1040
Synonymous	-0.219	88	85.4	1.03	0.00000410	910
Loss of Function	0.985	11	15.1	0.727	6.48e-7	223

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.000270	0.000268
Ashkenazi Jewish	0.00119	0.00119
East Asian	0.000381	0.000381
Finnish	0.0000462	0.0000462
European (Non-Finnish)	0.000229	0.000220
Middle Eastern	0.000381	0.000381
South Asian	0.0000327	0.0000327
Other	0.00	0.00

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Adds the third glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation. Transfers glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide Glc(2)Man(9)GlcNAc(2)-PP-Dol.
• Pathway: N-Glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation (Consensus)

Intolerance Scores

• loftool: 0.652
• rvis_EVS: -0.29
• rvis_percentile_EVS: 33.2

Haploinsufficiency Scores

• pHI: 0.302
• hipred: N
• hipred_score: 0.216
• ghis: 0.606

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.372

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Alg10b
• Phenotype: skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan)

Gene ontology

• Biological process: dolichol-linked oligosaccharide biosynthetic process
• Cellular component: endoplasmic reticulum membrane;integral component of membrane
• Molecular function: dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity;dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity